RT Journal Article
SR Electronic
T1 An Evidence-Based Methodological Framework for Pandemic Preparedness to Support the Clinical Trial Unit Workforce
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.03.17.23287311
DO 10.1101/2023.03.17.23287311
A1 Phiri, Peter
A1 Shi, Jian Qing
A1 Cavalini, Heitor
A1 Yardley, Lucy
A1 Barnard-Kelly, Katharine
A1 Sajid, Sana
A1 Raymont, Vanessa
A1 Rathod, Shanaya
A1 Delanerolle, Gayathri
YR 2023
UL http://medrxiv.org/content/early/2023/03/19/2023.03.17.23287311.abstract
AB Aims This study reports a new workforce preparedness framework for use during pandemics, specifically within clinical trials units.Methods An evidence-based framework was developed using qualitative and quantitative data, as reported by the EPIC observational study. A framework methodology was used to analyse qualitative and quantitative data to identify themes. The themes were used to identify sub-themes that were codes with illustrative quotes. A logic model was develop using spatial features.Results The qualitative component of the study included the views of 6 semi- structured interviews where discussions indicated the need for flexible working, requirement for better operational management, and access to electronic data systems remotely.Conclusion Significant mental health impact on the CTU workforce can be prevented by the introduction of a framework to streamline operational delivery of research, providing flexible working patterns to the workforce, and improved access to health and wellbeing practices. Funding calls should be made available to conduct further workforce-based research in the UK and to develop evidence-based policies to better prepare for future pandemics.What is already known?What is already known?Epidemic preparedness data indicate many countries remain unpreparedThere are large gaps in knowledge and practice base for continuity of research conduct during a lock-down circumstancesGeneric pandemic preparedness frameworks were available although these had limited relevance to Higher Education Institutions (HEIs) and National Health Services (NHS) that conduct significant volumes of clinical research studiesWhat are the new findings?What are the new findings?Epidemic Preparedness Index (EPI) that uses a ranking approach in 188 countries have been developed. The EPI includes health capacities and capabilities, including non-healthcare system featuresThe use of EPI scores to correlate with proxy measure for preparedness including detection, investigation and reporting of any outbreaks as well as vaccination rates. Examples include the UK flue vaccination rates and the 2009 H1N1 influenza pandemicCapacity to detect and respond to epidemics and pandemic appear to be weak across a number of global regions including Asia and Africa despite the higher risk of emergence of pathogensImpact of a pandemic on the healthcare and clinical research workforce is significant. There are many limitations in terms of the support available to manage their own wellbeingDifferent levels of complexities exist globally in terms of research regulations and legislations which impact the efficiency of setting up and conducting a studyThe impact of the pandemic to clinical trial unit staff in the UK indicated a number of aspects that need to be improved pertinent at an organisational and individual levelWhat do the new findings imply?What do the new findings imply?Healthcare and Academic institutions as well as the internal units require fit-for-purpose preparedness proceduresImproved risk planning and mitigation frameworks would be required to better understand and develop methods to continue to deliver workCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThis work is funded by the NIHRAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee the Health Research Authority of the UK gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript